The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global DNA Repair Drugs Market Research Report 2024

Global DNA Repair Drugs Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1806089

No of Pages : 105

Ask Your Query

Synopsis

DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.

The global DNA Repair Drugs market was valued at US$ 593.6 million in 2023 and is anticipated to reach US$ 1993.3 million by 2030, witnessing a CAGR of 18.4% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for DNA Repair Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Repair Drugs.

Report Scope

The DNA Repair Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Repair Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the DNA Repair Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • 4SC AG
  • ARCAGY/ GINECO GROUP
  • Bristol Myers Squibb
  • British Columbia Cancer Agency
  • Cambridge University Hospitals NHS Foundation Trust
  • Genentech
  • Georgetown University
  • German Breast Group
  • GlaxoSmithKline
  • Jiangsu Hengrui Medicine
  • Johnson & Johnson
  • Jonsson Comprehensive Cancer Center
  • Karyopharm Therapeutics
  • KuDOS Pharmaceuticals
  • National Health Service
  • National Institutes of Health
  • Tesaro

Segment by Type

  • PARP Inhibitors
  • Other

Segment by Application

  • Oncological
  • Stroke

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DNA Repair Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 DNA Repair Drugs Market Overview
1.1 Product Overview and Scope of DNA Repair Drugs
1.2 DNA Repair Drugs Segment by Type
1.2.1 Global DNA Repair Drugs Market Value Comparison by Type (2024-2030)
1.2.2 PARP Inhibitors
1.2.3 Other
1.3 DNA Repair Drugs Segment by Application
1.3.1 Global DNA Repair Drugs Market Value by Application: (2024-2030)
1.3.2 Oncological
1.3.3 Stroke
1.4 Global DNA Repair Drugs Market Size Estimates and Forecasts
1.4.1 Global DNA Repair Drugs Revenue 2019-2030
1.4.2 Global DNA Repair Drugs Sales 2019-2030
1.4.3 Global DNA Repair Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 DNA Repair Drugs Market Competition by Manufacturers
2.1 Global DNA Repair Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global DNA Repair Drugs Average Price by Manufacturers (2019-2024)
2.4 Global DNA Repair Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DNA Repair Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DNA Repair Drugs, Product Type & Application
2.7 DNA Repair Drugs Market Competitive Situation and Trends
2.7.1 DNA Repair Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DNA Repair Drugs Players Market Share by Revenue
2.7.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DNA Repair Drugs Retrospective Market Scenario by Region
3.1 Global DNA Repair Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global DNA Repair Drugs Global DNA Repair Drugs Sales by Region: 2019-2030
3.2.1 Global DNA Repair Drugs Sales by Region: 2019-2024
3.2.2 Global DNA Repair Drugs Sales by Region: 2025-2030
3.3 Global DNA Repair Drugs Global DNA Repair Drugs Revenue by Region: 2019-2030
3.3.1 Global DNA Repair Drugs Revenue by Region: 2019-2024
3.3.2 Global DNA Repair Drugs Revenue by Region: 2025-2030
3.4 North America DNA Repair Drugs Market Facts & Figures by Country
3.4.1 North America DNA Repair Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America DNA Repair Drugs Sales by Country (2019-2030)
3.4.3 North America DNA Repair Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe DNA Repair Drugs Market Facts & Figures by Country
3.5.1 Europe DNA Repair Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe DNA Repair Drugs Sales by Country (2019-2030)
3.5.3 Europe DNA Repair Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DNA Repair Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific DNA Repair Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific DNA Repair Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific DNA Repair Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America DNA Repair Drugs Market Facts & Figures by Country
3.7.1 Latin America DNA Repair Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America DNA Repair Drugs Sales by Country (2019-2030)
3.7.3 Latin America DNA Repair Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa DNA Repair Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa DNA Repair Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa DNA Repair Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global DNA Repair Drugs Sales by Type (2019-2030)
4.1.1 Global DNA Repair Drugs Sales by Type (2019-2024)
4.1.2 Global DNA Repair Drugs Sales by Type (2025-2030)
4.1.3 Global DNA Repair Drugs Sales Market Share by Type (2019-2030)
4.2 Global DNA Repair Drugs Revenue by Type (2019-2030)
4.2.1 Global DNA Repair Drugs Revenue by Type (2019-2024)
4.2.2 Global DNA Repair Drugs Revenue by Type (2025-2030)
4.2.3 Global DNA Repair Drugs Revenue Market Share by Type (2019-2030)
4.3 Global DNA Repair Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global DNA Repair Drugs Sales by Application (2019-2030)
5.1.1 Global DNA Repair Drugs Sales by Application (2019-2024)
5.1.2 Global DNA Repair Drugs Sales by Application (2025-2030)
5.1.3 Global DNA Repair Drugs Sales Market Share by Application (2019-2030)
5.2 Global DNA Repair Drugs Revenue by Application (2019-2030)
5.2.1 Global DNA Repair Drugs Revenue by Application (2019-2024)
5.2.2 Global DNA Repair Drugs Revenue by Application (2025-2030)
5.2.3 Global DNA Repair Drugs Revenue Market Share by Application (2019-2030)
5.3 Global DNA Repair Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 4SC AG
6.1.1 4SC AG Corporation Information
6.1.2 4SC AG Description and Business Overview
6.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 4SC AG DNA Repair Drugs Product Portfolio
6.1.5 4SC AG Recent Developments/Updates
6.2 ARCAGY/ GINECO GROUP
6.2.1 ARCAGY/ GINECO GROUP Corporation Information
6.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
6.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
6.2.5 ARCAGY/ GINECO GROUP Recent Developments/Updates
6.3 Bristol Myers Squibb
6.3.1 Bristol Myers Squibb Corporation Information
6.3.2 Bristol Myers Squibb Description and Business Overview
6.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
6.3.5 Bristol Myers Squibb Recent Developments/Updates
6.4 British Columbia Cancer Agency
6.4.1 British Columbia Cancer Agency Corporation Information
6.4.2 British Columbia Cancer Agency Description and Business Overview
6.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
6.4.5 British Columbia Cancer Agency Recent Developments/Updates
6.5 Cambridge University Hospitals NHS Foundation Trust
6.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
6.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
6.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
6.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments/Updates
6.6 Genentech
6.6.1 Genentech Corporation Information
6.6.2 Genentech Description and Business Overview
6.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Genentech DNA Repair Drugs Product Portfolio
6.6.5 Genentech Recent Developments/Updates
6.7 Georgetown University
6.6.1 Georgetown University Corporation Information
6.6.2 Georgetown University Description and Business Overview
6.6.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Georgetown University DNA Repair Drugs Product Portfolio
6.7.5 Georgetown University Recent Developments/Updates
6.8 German Breast Group
6.8.1 German Breast Group Corporation Information
6.8.2 German Breast Group Description and Business Overview
6.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 German Breast Group DNA Repair Drugs Product Portfolio
6.8.5 German Breast Group Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson DNA Repair Drugs Description and Business Overview
6.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Jonsson Comprehensive Cancer Center
6.12.1 Jonsson Comprehensive Cancer Center Corporation Information
6.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Description and Business Overview
6.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
6.12.5 Jonsson Comprehensive Cancer Center Recent Developments/Updates
6.13 Karyopharm Therapeutics
6.13.1 Karyopharm Therapeutics Corporation Information
6.13.2 Karyopharm Therapeutics DNA Repair Drugs Description and Business Overview
6.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
6.13.5 Karyopharm Therapeutics Recent Developments/Updates
6.14 KuDOS Pharmaceuticals
6.14.1 KuDOS Pharmaceuticals Corporation Information
6.14.2 KuDOS Pharmaceuticals DNA Repair Drugs Description and Business Overview
6.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
6.14.5 KuDOS Pharmaceuticals Recent Developments/Updates
6.15 National Health Service
6.15.1 National Health Service Corporation Information
6.15.2 National Health Service DNA Repair Drugs Description and Business Overview
6.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 National Health Service DNA Repair Drugs Product Portfolio
6.15.5 National Health Service Recent Developments/Updates
6.16 National Institutes of Health
6.16.1 National Institutes of Health Corporation Information
6.16.2 National Institutes of Health DNA Repair Drugs Description and Business Overview
6.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 National Institutes of Health DNA Repair Drugs Product Portfolio
6.16.5 National Institutes of Health Recent Developments/Updates
6.17 Tesaro
6.17.1 Tesaro Corporation Information
6.17.2 Tesaro DNA Repair Drugs Description and Business Overview
6.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tesaro DNA Repair Drugs Product Portfolio
6.17.5 Tesaro Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DNA Repair Drugs Industry Chain Analysis
7.2 DNA Repair Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DNA Repair Drugs Production Mode & Process
7.4 DNA Repair Drugs Sales and Marketing
7.4.1 DNA Repair Drugs Sales Channels
7.4.2 DNA Repair Drugs Distributors
7.5 DNA Repair Drugs Customers
8 DNA Repair Drugs Market Dynamics
8.1 DNA Repair Drugs Industry Trends
8.2 DNA Repair Drugs Market Drivers
8.3 DNA Repair Drugs Market Challenges
8.4 DNA Repair Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock